OBN’s Most Exclusive Event: The Annual Senior Executive Dinner  

Join us for this year’s most exclusive invitation-only senior executive dinner.

Enjoy a summer evening of relaxed networking with senior executives of the highest calibre in a beautiful riverside setting at one of Oxford’s very best restaurants. Be seen alongside some of the most influential R&D companies and investors (such as Vertex, Circassia, Polytherics, Glide and Evotec) for a bubbly networking reception followed by a sumptuous three-course meal and good wine.

Service Provider participation has been limited to a maximum of one representative from each of our sponsors. All companies will receive a complimentary copy of E&Y’s Beyond Borders Report, the Global Biotech Bible on the state of the industry and the way forward. This event is kindly sponsored by Ernst and Young.

Don’t miss the opportunity to raise your profile at this year’s most exclusive networking opportunity.

Menu:

Gravadlax with mixed greens
***
Rump of Dexter beef, spring greens and potato puree
***
Lemon Tart with raspberries
***
Tea, coffee and mints
(pre-arranged dietary requirements catered for)

Who else is attending?

Senior Managers, Directors and Partners from the following 50 biotech, *investment and pharma firms from across the Oxford & South-East, London, and Cambridge clusters and beyond are featured on the growing confirmation list for this most exclusive event.

Adaptimmune
AMS Biotechnology (Europe)
Apitope
BioAnaLab/Millipore
Biota Europe
Biotech Personnel
Cancer Research Technology
CellCentric
Chroma Therapeutics
Circassia
Coller IP Management
Constellation Technologies
De Facto Communications
Ernst & Young LLP
e-Therapeutics
Evotec (UK)
Genetix
GFC Diagnostics
Glide Pharma
g-Nostics
Immunocore
*IPSO Ventures
Isis Innovation
Isogenica
IXO
James Cowper LLP
*Kurma Biofund
London Genetics
Manches LLP
*Matrix Corporate Capital LLP
McEwen Laboratories
Merck & Co Inc
Neuropharm Group Plc
Novolytics
O2h
OBN
Orthox
*Oxford Capital Partners
Oxford Gene Technology
Physiomics plc
PolyTherics
Syntaxin
United Therapeutics Europe
Vernalis Group plc
Vertex Pharmaceuticals (Europe)

Costs: £49 + VAT for OBN members, sponsors and investors; £79 + VAT for non-members.   Non-R&D company participation is limited to one representative of each OBN Corporate Sponsor and OBN directors.

To contact us regarding this event, please email us at: events@obn.org.uk

You can find out more about joining OBN to receive the above benefits via our website: http://www.obn.org.uk

Payment: Payment is required in advance by invoice or Credit Card

Cancellation policy: In the event that you cancel your reservation one week prior to the event, full refund is available, less 25% Admin fee. Cancellation later than 1 week, no refund is available. Substitutions can be made up to 24 hours before the event